About Nifty Labs Private Limited
Data last updated: 23 December 2025
Nifty Labs Private Limited is a private limited company based in Aran Road, Ameerpet, Hyd-016, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 16 March 2005, the company has been in operation for over 21 years.
Registered with ROC Hyderabad under CIN U24239TG2005PTC045637.
Capital: an authorised share capital of ₹8 Cr and a paid-up capital of ₹6.84 Cr. It is led by directors including Desireddy Kesava Reddy and Krishna Reddy Bhimireddy.
Last AGM: 28 September 2024. Financial statements filed for year ended 31 March 2024. Office: Aran Road Ameerpet Hyd – 016, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹206.98 Cr, a growth of 30% compared to the previous year.
The company has a workforce of approximately 317 employees as per the latest available data.
The company is associated with 1 brand - Nifty Labs. As per MCA filings, the company has open charges of ₹58.61 Cr and satisfied charges of ₹13.21 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website niftylabs.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressFlat No.203 House No.7 – 1 – 54/1 Satya Sai Residency Dharam K Aran Road, Ameerpet Hyd – 016, Aran Road Ameerpet Hyd – 016, Telangana, India
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Nifty Labs Private Limited
Nifty Labs Private Limited has one previous CIN (Corporate Identification Number): U24239AP2005PTC045637. The current CIN is U24239TG2005PTC045637, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2005PTC045637 | Current |
| U24239AP2005PTC045637 | Previous |
Associated Brands with Nifty Labs Private Limited
Nifty Labs Private Limited operates one associated brand: Nifty Labs. These brands represent Nifty Labs Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provides comprehensive solutions for API manufacturing and regulatory affairs. | niftylabs.com |
Competitors & Alternatives of Nifty Labs Private Limited
Brands and companies operating in the same space as Nifty Labs Private Limited include WuXi AppTec, ANI Pharmaceuticals, Aptar and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
WuXi AppTec
|
Provider of CRO and CDMO services | Shanghai, China, China | 2000 |
ANI Pharmaceuticals
|
Branded and generic prescription drugs are developed, manufactured, and marketed. | Baudette, United States, United States | 1996 |
Aptar
|
Regulatory support, brand differentiation, and prototyping services are provided. | Crystal Lake, United States, United States | 1992 |
CHEPLAPHARM
|
Branded pharmaceutical products are developed, marketed, and distributed globally. | Mesekenhagen, Germany, Germany | 1998 |
Red Nucleus
|
Advisory, scientific, and medical communications provided for pharmaceutical industry. | Yardley, United States, United States | 2014 |
Ipsen
|
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | - | 1929 |
Eurofins Scientific
|
Laboratory testing and contract research services are provided globally. | Luxembourg, Luxembourg, Luxembourg | 1987 |
China Medical System
|
Generic formulations including tablets, capsules, liquids, and injectables are manufactured. | Shenzhen, China, China | 1992 |
Aliada Therapeutics
|
Provider of drug research & development services for multiple therapeutic areas | Boston, United States, United States | 2021 |
Business Activity of Nifty Labs Private Limited
Nifty Labs Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Nifty Labs Private Limited
Nifty Labs Private Limited is audited by Suryanarayana Reddy & Co., for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Suryanarayana Reddy & Co., | blur-value | blur-value | blur-value |
Board of Directors of Nifty Labs Private Limited
Nifty Labs Private Limited is currently managed by 4 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Desireddy Kesava Reddy
Also directs:
Nifty Pharma Private Limited
|
Managing Director | 16 Mar 2005 | 21 Years 3 Months | Current |
| Krishna Reddy Bhimireddy | Whole-Time Director | 16 Mar 2005 | 21 Years 3 Months | Current |
|
Bharath Reddy Yerram
Also directs:
Nifty Pharma Private Limited
|
Whole-Time Director | 16 Mar 2005 | 21 Years 3 Months | Current |
|
Neha Reddy Desireddy
Also directs:
Nifty Pharma Private Limited
|
Director | 14 Jun 2024 | 2 Years 0 Months | Current |
Financials of Nifty Labs Private Limited FY 2024 filings available
Nifty Labs Private Limited reported revenue of ₹206.98 Cr (up 30% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Nifty Labs Private Limited
As of FY 2023, Nifty Labs Private Limited's shareholding pattern shows 56.73% by promoters, 43.28% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Group Structure of Nifty Labs Private Limited
Nifty Labs Private Limited has 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Nifty Labs Private Limited's business expansion strategy and organizational complexity.
Charges & Borrowings of Nifty Labs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Aug 2025 | Others | ₹38.25 Lakh | Open |
| 24 Jun 2024 | Others | ₹7.2 Cr | Open |
| 30 Jan 2021 | Others | ₹12 Cr | Open |
| 26 Dec 2013 | State Bank of India | ₹39.03 Cr | Open |
| 09 Mar 2021 | Hdfc Bank Limited | ₹34.79 Lakh | Satisfied |
Total charge records: 10 View all charges
Employees and EPFO Compliance at Nifty Labs Private Limited
Nifty Labs Private Limited has a workforce of 317 employees as of Apr 08, 2024.
Employee Count & EPFO Data of Nifty Labs Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Nifty Labs Private Limited
GSTIN & GST Filing Data of Nifty Labs Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Nifty Labs Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Nifty Labs Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Nifty Labs Private Limited
MSME Payment Delays by Nifty Labs Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Nifty Labs Private Limited
Subsidiaries & Group Companies of Nifty Labs Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Nifty Labs Private Limited with ownership details.
MCA Filings & Documents of Nifty Labs Private Limited
MCA Filings & Documents of Nifty Labs Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Nifty Labs Private Limited
Frequently Asked Questions about Nifty Labs Private Limited
Nifty Labs Private Limited is an active private limited company in the pharma sector based in Aran Road, Ameerpet, Hyd-016, Telangana, India. It was incorporated on 16 March 2005 (21+ years old) and is registered under CIN U24239TG2005PTC045637. The company has 317 employees.
Nifty Labs Private Limited reported revenue of ₹206.98 Cr for FY 2025 (up 30.00% YoY).
The current directors of Nifty Labs Private Limited are:
The primary industry of Nifty Labs Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Nifty Labs Private Limited can be reached at the registered office: Flat No.203 House No.7 – 1 – 541 Satya Sai Residency Dharam K Aran Road, Ameerpet Hyd – 016, Aran Road Ameerpet Hyd – 016, Telangana, India, or through the website niftylabs.com.
The authorised capital is ₹8 Cr, and the paid-up capital is ₹6.84 Cr.